Publication Name	World Journal of Gastrointestinal Oncology
Manuscript ID	93301
Country	Singapore

Received	2024-02-24 08:29
Peer-Review Started	2024-02-24 08:29
To Make the First Decision
Return for Revision	2024-04-17 03:36
Revised	2024-05-17 18:35
Second Decision	2024-06-14 02:42
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-06-14 07:28
Articles in Press	2024-06-14 07:28
Publication Fee Transferred
Edit the Manuscript by Language Editor	2024-06-20 04:07
Typeset the Manuscript	2024-07-10 00:41
Publish the Manuscript Online	2024-09-26 10:17

ISSN	1948-5204 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Medicine, General & Internal
Manuscript Type	Editorial
Article Title	Improving clinical outcomes of patients with hepatocellular carcinoma: Role of antiviral therapy, conversion therapy, and palliative therapy
Manuscript Source	Invited Manuscript
All Author List	Vishal G Shelat
ORCID	Author(s) ORCID Number Vishal G Shelat http://orcid.org/0000-0003-3988-8142
Funding Agency and Grant Number
Corresponding Author	Vishal G Shelat, Visiting Professor, FICS, FRCS (Ed), MBBS, MMed, MNAMS, MS, Adjunct Associate Professor, Department of General Surgery, Tan Tock Seng Hospital, 11 Jalan Tan Tock Seng, Singapore 308433, Singapore. vgshelat@rediffmail.com
Key Words	Antivirals; Chemoembolization; Conversion therapy; Hepatocellular carcinoma; Lenvatinib; Neutrophil-to-lymphocyte ratio
Core Tip	Hepatocellular carcinoma (HCC) is a common cancer, and the treatment approaches are evolving. The outcomes of liver resection patients can be improved by early diagnosis, robust implementation of screening programs, and pre-operative antiviral therapy for patients who qualify for it. In patients managed with multimodality treatment, downstaging and conversion to surgical resection remain possible. Simple serological markers can be useful for predicting response to curative or palliative intent treatment of HCC patients.
Publish Date	2024-09-26 10:17
Citation	<p>Shelat VG. Improving clinical outcomes of patients with hepatocellular carcinoma: Role of antiviral therapy, conversion therapy, and palliative therapy. <i>World J Gastrointest Oncol</i> 2024; 16(10): 4037-4041</p>
URL	https://www.wjgnet.com/1948-5204/full/v16/i10/4037.htm
DOI	https://dx.doi.org/10.4251/wjgo.v16.i10.4037

Full Article (PDF)	WJGO-16-4037-with-cover.pdf
Manuscript File	93301-Review-Filipodia-check-YJP.docx
Answering Reviewers	93301-answering-reviewers.pdf
Audio Core Tip	93301-audio.m4a
Conflict-of-Interest Disclosure Form	93301-conflict-of-interest-statement.pdf
Copyright License Agreement	93301-copyright-assignment.pdf
Peer-review Report	93301-peer-reviews.pdf
Scientific Misconduct Check	93301-scientific-misconduct-check.png
Scientific Editor Work List	93301-scientific-editor-work-list.pdf
CrossCheck Report	93301-crosscheck-report.pdf